MEPED as salvage therapy for relapsed/refractory Hodgkin’s lymphoma incorporating edited non-oncogene addiction: mTOR as a bottleneck by Dennis Christoph Harrer, Florian Lüke, Florian Lüke, Tobias Pukrop, Tobias Pukrop, Lina Ghibelli, Albrecht Reichle, Daniel Heudobler, Daniel Heudobler

Get full text

Preliminary effectiveness of social prescription and virtual patient information in increasing tertiary prevention among cancer patients (ESPRIT): protocol for a single-centre, ran... by Karen Steindorf, Michael Koller, Michael Leitzmann, Wolfgang Herr, Daniel Heudobler, Lisa Boyer, Anne Herrmann, Tobias Pukrop, Christine Bernardi, Sabine Einhell

Get full text

MetInfilt: A prospective trial highlighting the importance of the histological growth pattern in brain metastases by Martin A. Proescholdt, Tommaso Araceli, Karl-Michael Schebesch, Christian Doenitz, Christina Wendl, Katja Evert, Ekaterina Noeva, Julius Hoehne, Markus J. Riemenschneider, Daniela Hirsch, Nils Ole Schmidt, Daniela Sparrer, Florian Lüke, Daniel Heudobler, Tobias Pukrop, Raquel Blazquez

Get full text

Cellular liquid biopsy provides unique chances for disease monitoring, preclinical model generation and therapy adjustment in rare salivary gland cancer patients by Nataša Stojanović Gužvić, Florian Lüke, Steffi Treitschke, Andrea Coluccio, Martin Hoffmann, Giancarlo Feliciello, Adithi Ravikumar Varadarajan, Xin Lu, Kathrin Weidele, Catherine Botteron, Silvia Materna–Reichelt, Felix Keil, Katja Evert, Florian Weber, Thomas Schamberger, Michael Althammer, Jirka Grosse, Dirk Hellwig, Christian Schulz, Stephan Seitz, Peter Ugocsai, Anke Schlenska‐Lange, Roman Mayr, Ulrich Kaiser, Wolfgang Dietmaier, Bernhard Polzer, Jens Warfsmann, Kamran Honarnejad, Tobias Pukrop, Daniel Heudobler, Christoph A. Klein, Christian Werno

Get full text